Ontuxizumab (Anti-TEM1 / Endosialin / CD248)

Ontuxizumab (Anti-TEM1/endosialin/ CD248) is a humanized IgG1/κ anti-endosialin (TEM-1 or CD248) monoclonal antibody with potential anti-angiogenic and antineoplastic activities. MW : 145.5 KD
Supplier Selleck Chemicals
Product # A2338
Sku # A2338-1mg*5
Pricing 1mg*5, $970.00
Feedback